Table 1 Baseline characteristics of subjects in the LIPC and Sham groups

Age, (years)

56.93 ± 14.39

53.44 ± 11.10

0.287

Males, n (%)

20(66.7)

18(56.3)

0.4

SBP, (mmHg)

147.03 ± 21.61

140.88 ± 22.36

0.275

DBP, (mmHg)

86.57 ± 12.67

85.84 ± 12.22

0.82

HR, (beats/min)

79.00(72.75,84.00)

78.50(76.00,83.75)

0.507

BMI, (kg/m2)

22.15(20.30,24.55)

21.96(20.24,25.51)

0.978

Smoking History, (%)

12(40.0)

10(31.3)

0.472

Duration of dialysis, (months)

48(24,93)

37(21,81)

0.621

Hypertension, n(%)

29(96.7)

31(96.9)

1.0

DM, n (%)

9(30.0)

10(31.3)

0.915

statin drug, n(%)

14(46.7)

15(46.9)

0.987

insulin, n(%)

5(15.6)

6(18.8)

0.83

antihyperglycemic drug, n(%)

2(6.7)

1(3.1)

0.516

Glycated hemoglobin, (%)

5.50(5.28,5.88)

5.75(5.33,6.10)

0.142

Hemoglobin, (g/L)

105.17 ± 15.05

111.56 ± 15.92

0.11

PTH, (ng/L)

172.55(112.00,337.53)

229.20(84.78,389.38)

0.583

Albumin, (g/L)

39.91 ± 3.59

40.10 ± 4.37

0.858

glucose, (mmol/L)

5.66(4.74,6.73)

5.40(4.70,6.99)

0.8

BUN, (mmol/L)

22.01 ± 10.05

21.65 ± 6.95

0.871

Creatinine, (µmol/L)

818.97 ± 297.15

869.07 ± 230.80

0.46

UA, (µmol/L)

349.33 ± 142.65

360.48 ± 107.00

0.728

TC, (mmol/L)

4.00(3.64,5.16)

3.81(3.07,4.32)

0.17

Triglyceride, (mmol/L)

1.53(1.35,2.37)

1.47(1.03,2.04)

0.118

HDL-C, (mmol/L)

1.00(0.75,1.15)

1.04(0.84,1.19)

0.36

LDL-C, (mmol/L)

2.17(1.88,2.86)

1.94(1.47,2.61)

0.13

spKt/V

1.34 ± 0.09

1.32 ± 0.08

0.461